CML

(redirected from chronic myelocytic leukemia)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to chronic myelocytic leukemia: myelogenous, chronic granulocytic leukemia

CML

Capital Market Line

In the capital asset pricing model, a line that plots the extra return an investor expects for each change in the level of risk. Rational investors expect higher returns for riskier assets and the capital market line shows this graphically. A portfolio that accurately reflects the capital market line is considered a Markowitz efficient portfolio. The slope of the capital market line is a calculation of the equilibrium market price of risk. See also: Beta.
References in periodicals archive ?
* The report provides a snapshot of the global therapeutic landscape of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
A three way complex translocation (4;9;22) in two patients with chronic myelocytic leukemia. J Cancer Res Ther 2005;1:108-10 (BRIEF COMMUNICATIONS),
Translocation of c-abl oncogene correlates with the presence of Philadelphia chromosome in chronic myelocytic leukemia. Nature.
CHRONIC MYELOGENOUS LEUKEMIA (CML) - also known as Chronic Granulocytic Leukemia (CGL), Chronic Myelocytic Leukemia, Chronic Myelosis or Chronic Myeloid Leukemia - is one of the four main type of leukemia, accounting for 20 percent to 25 percent of all leukemia cases.
Global Markets Direct's, 'Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016', provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) pipeline landscape.
Treatment of chronic myelocytic leukemia (CML) with imatinib is encouraging and it has an acceptable toxicity profile, and as such has changed the management of CML during the last decade.

Full browser ?